Conduent Inc Stock Price, News & Analysis

Conduent (NASDAQ: CNDT) reported its Q1 2025 financial results with mixed performance. The company recorded revenue of $751 million, representing an 18.5% year-over-year decline, and an adjusted revenue decline of 8.5%. The company posted a pre-tax loss of $56 million, compared to a profit of $127 million in Q1 2024, primarily due to the prior year's BenefitWallet portfolio transfer gain.

Despite challenges, there were some positive indicators: Adjusted EBITDA increased to $37 million with a margin of 4.9%, showing improvement from 4.4% in Q1 2024. New business signings and Net ARR Activity Metric showed year-over-year improvement. The company maintained a strong liquidity position with $293 million in cash and an largely undrawn $550 million credit facility.

Conduent reaffirmed its FY 2025 outlook, projecting adjusted revenue between $3.1-3.25 billion and adjusted EBITDA margin of 4.5-5.5%. The company also highlighted several new contract wins and technological achievements, including AI implementations and transit system modernizations.

Conduent (Nasdaq: CNDT) has announced it will release its first-quarter 2025 financial results on Wednesday, May 7, 2025, before the market opens. The company will host a conference call and webcast at 9:00 a.m. ET on the same day to discuss the results.

Investors can access the live audiocast and presentation slides at investor.conduent.com. The conference call can be joined via toll-free number 877-407-4019 (Conference ID: 13752430) or internationally at +1 201-689-8337. A recording will be available for replay until May 20, 2025, by calling 877-660-6853 with access ID 13752430.

Conduent (Nasdaq: CNDT) has been honored as a 2024 Supplier of the Year by General Motors at GM's 33rd annual Supplier of the Year event in Phoenix, Arizona. This marks the third time Conduent has received this prestigious recognition from GM.

The award highlights the successful partnership between the two companies, with Conduent demonstrating strong business outcomes and deep understanding of GM's operations. Mike McDaniel, Group President, Commercial Solutions at Conduent, emphasized the significance of this recognition as a testament to the seamless collaboration between both organizations.

Conduent Transportation (Nasdaq: CNDT) has secured a contract with NJ TRANSIT to install advanced 3D fare gates at two New Jersey stations. The nearly 8-foot-tall gates will be implemented at Secaucus Junction and Newark Liberty International Airport stations, with a total of 72 gates planned.

This agreement follows a recent 2024 contract with SEPTA for 100 fare gates across nine Philadelphia-area stations. The implementation builds upon Conduent's 30-year partnership with NJ TRANSIT and comes after NJ TRANSIT awarded a five-year contract to Conduent in 2024 for contactless fare collection system enhancement.

The technology has proven successful in Paris with Transilien SNCF, and SEPTA's pilot program demonstrated increased annual revenue through improved fare evasion deterrence when combined with transit police efforts.

Conduent (Nasdaq: CNDT) has secured a five-year contract with Ireland's Health Service Executive (HSE) to implement its Maven® Disease Surveillance & Outbreak Management System. This marks Maven's first deployment in the European Union, expanding its presence beyond existing implementations in the US, UK, and Australia.

The cloud-hosted platform will replace HSE's legacy surveillance system, enabling automated disease event generation upon receiving case or laboratory reports. The system can track over 100 communicable and non-communicable diseases, including COVID-19, C. auris, Mpox, Ebola, Zika, measles, tuberculosis, HIV/STDs, and influenza.

The Maven system will provide HSE with enhanced capabilities for early detection, monitoring, and response to public health threats across Ireland. The contract includes maintenance, support, and access to Conduent's Maven Users Group, a global community of public health officials sharing best practices.

Conduent (CNDT) reported its Q4 and full year 2024 financial results. Q4 revenue was $800M, down 16.1% year-over-year, while full-year revenue reached $3,356M, down 9.8% from 2023. The company completed three strategic divestitures in 2024, including BenefitWallet ($425M), Curbside Management and Public Safety ($230M), and Casualty Claims Solutions ($224M).

The company used divestiture proceeds to reduce debt, voluntarily prepaying all Term Loan B and $137M of Term Loan A, achieving a 50% debt reduction compared to 2023. Full-year 2024 pre-tax income was $504M, compared to a loss of $332M in 2023. The company completed a $75M share repurchase program, buying back 52M shares. For 2025, Conduent projects adjusted revenue between $3,100M-$3,250M with adjusted EBITDA margin of 4.5%-5.5%.

Conduent (NASDAQ: CNDT) has launched Conni, a new GenAI virtual assistant powered by Microsoft Azure OpenAI Service. The AI assistant will be integrated into multiple Conduent platforms, with its first implementation in the Life@Work® Connect Experience Platform, a centralized portal for employee benefits management.

Conni is designed to help employees navigate their benefits using natural language, providing personalized answers about health and wealth benefits, facilitating access to resources for life events, and managing health savings accounts. The system works within a secure closed environment and can seamlessly transition users to live support when needed.

The platform integrates with other AI-driven features like JellyVision and TALON, consolidating data from various sources to offer interactive content and guided recommendations for employee benefits management.

Conduent (NASDAQ: CNDT) announced that the Oklahoma State Department of Health (OSDH) has selected its Maven® Disease Surveillance & Outbreak Management System to replace their legacy public health surveillance system. The cloud-based platform will help OSDH monitor, track, and report public health threats and infectious disease outbreaks.

The AI-enabled system is currently used across 28 government agencies in the United States, Europe, and Australia. Maven enables real-time monitoring and reporting to local, state, and national public health organizations, capable of tracking over 100 communicable and non-communicable diseases including COVID-19, C. auris, Mpox, Ebola, Zika, measles, tuberculosis, HIV/STDs, and influenza.

The platform will serve Oklahoma's population of 4 million residents, providing tools for outbreak identification, case management, and collaboration with local healthcare partners.